The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 61 , ISSUE 4 ( October-December, 2019 ) > List of Articles

CASE REPORT

Fungal Pyopneumothorax: A Rare Entity

Shamim Mohammad, R.S. Pal, Ram Babu Sah, Sameer Vaidya, Saurabh Yadav

Keywords : Fungal empyema, Pyopneumothorax, Candida glabrata

Citation Information : Mohammad S, Pal R, Sah RB, Vaidya S, Yadav S. Fungal Pyopneumothorax: A Rare Entity. Indian J Chest Dis Allied Sci 2019; 61 (4):211-213.

DOI: 10.5005/ijcdas-61-4-211

License: CC BY-NC 4.0

Published Online: 18-11-2022

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Fungal empyema is rare but severe infection with high mortality. Candida spp are the most common isolates among all fungal empyema patients. Candida glabrata (older name: Torulopsis glabrata) is often the second or third most common cause of candidiasis after Candida albicans. Candida glabrata infections can be mucosal or systemic and are common in immunocompromised patients, especially in patients with diabetes mellitus. We report a case of fungal pyopneumothorax in a patient having underlying diabetes mellitus and cirrhosis of the liver. Candida glabrata, being an uncommon pathogen for fungal pyopneumothorax was the causative agent in the present case.


PDF Share
  1. Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, et al. Fungal empyema thoracis in cancer patients. J Infect 2016;72:615–21.
  2. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80–96.
  3. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–21.
  4. Ko SC, Chen KY, Hsueh PR, Luh KT, Yang PC. Fungal empyema thoracis: an emerging clinical entity. Chest 2000:117;1672–8.
  5. Lin KH, Liu YM, Lin PC, Ho CM, Chou CH, Wang JH, et al. Report of a 63-case series of Candida empyema thoracis: 9-year experience of two medical centers in central Taiwan. J Microbiol Immunol Infect 2014;47:36–41.
  6. Matsuda T, Koreeda Y, Mataki H, Taira T, Noma S, Higashimoto I, et al. A case of Aspergillus empyema successfully treated combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid. Intern Med 2010;49:1163–9.
  7. Weiler S, Bellmann-weiler R, Joannidis M, Bellmann R. Penetration of amphotericin B lipid formulation into pleural effusion. Antimicrob Agents Chemother 2007;51:4211–3.
  8. Vazquez JA, Dembry LM, Sanchez V, Vazquez MA, Sobel JD, Dmuchowski C, et al. Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol 1998;36:421–6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.